Elementis/£ELM
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Elementis
Elementis PLC, designated by the ticker ELM, is a global company specializing in the manufacture and sale of specialty chemicals. Established in 1844, the company primarily operates within the specialty chemicals industry, providing high-performance additives designed to enhance the capability of products across a diverse range of industries including personal care, coatings, talc, and chromium. Elementis is committed to delivering products that respond to the unmet needs and demands of their global clientele, focusing on quality, innovation, and sustainability.
- Ticker
- £ELM
- Sector
- Materials
- Primary listing
- LSE
- Employees
- 989
- Headquarters
- London, United Kingdom
- Website
- www.elementis.com
Elementis Metrics
BasicAdvanced
£1.1B
19.33
£0.10
0.92
£0.03
1.78%
Price and volume
Market cap
£1.1B
Beta
0.92
52-week high
£2.00
52-week low
£1.36
Average daily volume
1.1M
Dividend rate
£0.03
Financial strength
Current ratio
2.274
Quick ratio
1.375
Long term debt to equity
0.318
Total debt to equity
0.399
Dividend payout ratio (TTM)
33.47%
Interest coverage (TTM)
8.49%
Profitability
EBITDA (TTM)
122.208
Gross margin (TTM)
48.30%
Net profit margin (TTM)
11.86%
Operating margin (TTM)
22.15%
Effective tax rate (TTM)
30.12%
Revenue per employee (TTM)
£481,490
Management effectiveness
Return on assets (TTM)
7.66%
Return on equity (TTM)
10.67%
Valuation
Price to earnings (TTM)
19.333
Price to revenue (TTM)
2.25
Price to book
1.61
Price to tangible book (TTM)
14.41
Price to free cash flow (TTM)
38.523
Free cash flow yield (TTM)
2.60%
Free cash flow per share (TTM)
0.049
Dividend yield (TTM)
1.78%
Growth
Revenue change (TTM)
7.65%
Earnings per share change (TTM)
-198.87%
3-year revenue growth (CAGR)
-4.29%
10-year revenue growth (CAGR)
-0.41%
3-year earnings per share growth (CAGR)
18.61%
10-year earnings per share growth (CAGR)
-2.94%
10-year dividend per share growth (CAGR)
-6.11%
What the Analysts think about Elementis
Analyst ratings (Buy, Hold, Sell) for Elementis stock.
Analyst projections of the future price of Elementis stock.
Bulls say / Bears say
Nine-month organic constant-currency revenue rose 7% to $479m, and Elementis lifted its FY26 adjusted operating-profit guidance to $133m–$135m. That points to improving momentum, although the new range is in line with market expectations. (Investegate)
Skincare and suncare product launches featuring Elementis ingredients increased 25% in the first half, while sales in those applications grew at a double-digit rate. Wider use of hectorite in these markets gives the company a potential growth runway. (London Stock Exchange)
First-half adjusted operating profit rose 16.4% to $73.2m and the adjusted margin increased to 23.0% from 21.6%. Higher revenue and cost savings supported the improvement, alongside the benefit of a higher-margin business mix after the pharmaceutical business sale. (London Stock Exchange)
Elementis expects fourth-quarter revenue to be lower than in the third quarter, which benefited from customer orders being fulfilled earlier than expected. That makes the latest growth less certain as a guide to near-term trading. (Investegate)
Coatings trading remained uneven: weaker results in EMEA were offset by strength in Asia, while the company expects Asian growth to moderate in the fourth quarter against a strong comparison. This leaves a key division exposed to regional demand swings. (Investegate)
First-half operating cash inflow fell to $19.1m from $29.1m a year earlier, as working-capital outflows increased to $44.4m. If higher receivables and inventories do not unwind, cash conversion could lag the company’s ambitions. (London Stock Exchange)
Data summarised monthly by Lightyear AI. Last updated on 16 Nov 2026.
Elementis Financial Performance
Revenues and expenses
Elementis Earnings Performance
Company profitability
Upcoming events
No upcoming events
Funds containing Elementis
AllGBPUSD
Fund name | Fund size | £ELM weighting |
|---|---|---|
iShares FTSE 250£MIDD | £652M | 0.35% |
Vanguard FTSE 250£VMIG | £569M | 0.34% |
Vanguard FTSE 250£VMID | £1.5B | 0.34% |
Xtrackers MSCI Europe Small Cap€DX2J | $3.7B | 0.09% |
Xtrackers MSCI Europe Small Cap£XXSC | $3.7B | 0.09% |
Latest price is delayed by 15 minutes. Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by London Stock Exchange, through Infront.